early predictive value of plasma biomarkers for amyloid positivity
Published 1 year ago • 39 plays • Length 2:19Download video MP4
Download video MP3
Similar videos
-
6:37
blood-based biomarkers as surrogates of amyloid burden in preclinical alzheimer's disease
-
1:36
using plasma biomarkers in the diagnosis of alzheimer’s disease
-
6:13
biomarkers for early detection of alzheimer’s disease: micrornas
-
2:57
the potential of plasma biomarkers in dementia
-
0:56
biomarkers for risk assessment and early diagnosis of ad
-
1:58
the value of plasma p-tau181 as a screening and diagnostic tool for alzheimer’s disease
-
10:12
predicting amyloid pet and tau pet stages with plasma biomarkers
-
1:34
prognostic value of plasma biomarkers gfap and ptau181 for all-cause and alzheimer’s dementia
-
1:14
plasma tau levels and alzheimer’s disease: what’s the relationship?
-
1:23
plasma biomarkers for alzheimer's disease as pre-screening tools
-
3:19
prognostic blood biomarkers in the pre-clinical stages of alzheimer’s disease
-
5:34
associations between predicted brain age and alzheimer’s disease biomarkers
-
2:11
upcoming plasma biomarkers for alzheimer’s disease: aβ, p-tau and gfap
-
2:46
value of p-tau231 in early alzheimer’s disease
-
2:09
alzheimer’s disease plasma biomarkers across the spectrum: which perform best?
-
4:05
plasma biomarkers and genetics in the diagnosis and prediction of alzheimer’s disease
-
2:51
association of csf and plasma biomarkers with longitudinal tau accumulation
-
1:45
the use of alzheimer’s disease plasma biomarkers in the clinic: further research needed
-
1:32
investigating novel plasma-based p-tau biomarkers